[go: up one dir, main page]

CO6731081A2 - Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol - Google Patents

Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol

Info

Publication number
CO6731081A2
CO6731081A2 CO13117014A CO13117014A CO6731081A2 CO 6731081 A2 CO6731081 A2 CO 6731081A2 CO 13117014 A CO13117014 A CO 13117014A CO 13117014 A CO13117014 A CO 13117014A CO 6731081 A2 CO6731081 A2 CO 6731081A2
Authority
CO
Colombia
Prior art keywords
patients
gosipol
copolymer
producing
sodium carboxymethylcellulose
Prior art date
Application number
CO13117014A
Other languages
English (en)
Inventor
Feliz Ivanovich Ershov
Vladimir Georgievich Nesterenko
Abdushukur Abdukhalilovich Sarymsakov
Natalya Uryevna Alekseeva
Original Assignee
Ltd Liability Company Nearmedic Plus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd Liability Company Nearmedic Plus filed Critical Ltd Liability Company Nearmedic Plus
Publication of CO6731081A2 publication Critical patent/CO6731081A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/02—Alkyl or cycloalkyl ethers
    • C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

La invención se refiere al campo de la química orgánica, la farmacología y la medicina y se refiere a un método para producir un copolimero de carboximetilcelulosa sódica y gosipol, a su uso en terapia compleja de pacientes con trastornos del espectro autista y alteraciones cognitivas, así como una composición farmacéutica que comprende el mismo que va a usarse en el tratamiento de pacientes con trastornos del espectro autista y alteraciones cognitivas, a una combinación para el tratamiento de pacientes con trastornos del espectro autista y alteraciones cognitivas y aun método para tratar a tales pacientes.
CO13117014A 2010-10-11 2013-05-10 Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol CO6731081A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010141697/05A RU2453559C1 (ru) 2010-10-11 2010-10-11 Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями

Publications (1)

Publication Number Publication Date
CO6731081A2 true CO6731081A2 (es) 2013-08-15

Family

ID=45938511

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13117014A CO6731081A2 (es) 2010-10-11 2013-05-10 Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol

Country Status (27)

Country Link
US (1) US9078916B2 (es)
EP (1) EP2628754B8 (es)
JP (1) JP5690944B2 (es)
CN (1) CN103189393B (es)
AU (1) AU2011314406B2 (es)
BR (1) BR112013008888B1 (es)
CA (2) CA2896450A1 (es)
CL (2) CL2013000962A1 (es)
CO (1) CO6731081A2 (es)
CY (1) CY1119413T1 (es)
DK (1) DK2628754T3 (es)
EA (2) EA024810B1 (es)
EC (1) ECSP13012613A (es)
ES (1) ES2643167T3 (es)
GE (1) GEP201706607B (es)
HR (1) HRP20171330T1 (es)
HU (1) HUE034920T2 (es)
LT (1) LT2628754T (es)
PE (1) PE20140200A1 (es)
PL (1) PL2628754T3 (es)
PT (1) PT2628754T (es)
RS (1) RS56257B1 (es)
RU (1) RU2453559C1 (es)
SI (1) SI2628754T1 (es)
SM (1) SMT201700497T1 (es)
UA (2) UA108126C2 (es)
WO (1) WO2012050483A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2499002C1 (ru) * 2012-06-14 2013-11-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе
RU2577539C2 (ru) * 2014-06-17 2016-03-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе
RU2754067C2 (ru) * 2018-05-18 2021-08-25 Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение
RU2746504C1 (ru) * 2020-02-27 2021-04-14 Ниармедик Интернэшнл Лимитед Противомикробные средства на основе бета-глюканов, способы их получения и применения
CN114622407B (zh) * 2022-04-01 2023-09-19 浙江隆腾医用新材料有限公司 一种羧甲基纤维素钠纤维的洗脱方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2002755C1 (ru) * 1991-02-04 1993-11-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием
RU2222548C2 (ru) * 2000-07-21 2004-01-27 Зао "Ниармедик Плюс" Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе
AU2003247515A1 (en) * 2002-06-10 2003-12-22 Wyeth Novel formate salt of o-desmethyl-venlafaxine
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
RU2238122C1 (ru) * 2003-01-20 2004-10-20 Ооо "Ниармедик Плюс" Противоинфекционный фармацевтический препарат
RU2270708C1 (ru) * 2004-05-26 2006-02-27 Ооо "Ниармедик Плюс" Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний
US20060144723A1 (en) * 2004-11-02 2006-07-06 Mary Fuller Device for securing valuables
US20080299204A1 (en) * 2005-06-23 2008-12-04 Spherics, Inc. Dosage forms for movement disorder treatment
US20090285865A1 (en) * 2008-05-14 2009-11-19 Shalaby Shalaby W Palatable, solid oral formulations for male chemical sterilization

Also Published As

Publication number Publication date
US9078916B2 (en) 2015-07-14
PL2628754T3 (pl) 2017-12-29
PT2628754T (pt) 2017-10-19
EA201390530A1 (ru) 2013-07-30
EP2628754B1 (en) 2017-07-12
SMT201700497T1 (it) 2017-11-15
AU2011314406A1 (en) 2013-05-23
UA108126C2 (uk) 2015-03-25
LT2628754T (lt) 2017-11-10
RS56257B1 (sr) 2017-11-30
ECSP13012613A (es) 2013-10-31
EA024810B1 (ru) 2016-10-31
CL2015001180A1 (es) 2015-08-28
RU2010141697A (ru) 2012-04-20
CA2896450A1 (en) 2012-04-19
CN103189393A (zh) 2013-07-03
CY1119413T1 (el) 2018-03-07
AU2011314406B2 (en) 2016-08-11
BR112013008888B1 (pt) 2021-01-05
UA108975C2 (uk) 2015-06-25
CN103189393B (zh) 2015-09-30
CA2811583C (en) 2016-03-22
BR112013008888A2 (pt) 2016-06-28
CL2013000962A1 (es) 2013-12-06
EA201690544A1 (ru) 2016-07-29
JP2013540866A (ja) 2013-11-07
EP2628754B8 (en) 2017-10-25
WO2012050483A1 (ru) 2012-04-19
CA2811583A1 (en) 2012-04-19
PE20140200A1 (es) 2014-02-21
HUE034920T2 (en) 2018-03-28
RU2453559C1 (ru) 2012-06-20
JP5690944B2 (ja) 2015-03-25
EP2628754A1 (en) 2013-08-21
ES2643167T3 (es) 2017-11-21
SI2628754T1 (en) 2017-11-30
US20130266534A1 (en) 2013-10-10
DK2628754T3 (da) 2017-11-20
EA031316B1 (ru) 2018-12-28
GEP201706607B (en) 2017-01-25
HRP20171330T1 (hr) 2017-10-20
EP2628754A4 (en) 2014-03-26

Similar Documents

Publication Publication Date Title
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
MX2014002668A (es) Tratamiento de enfermedades relacionadas con subunidades alfa de canales de sonido regulados por voltaje (scnxa) con moleculas pequeñas.
ECSP19025350A (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
MX2021008113A (es) Composiciones farmaceuticas que comprenden un antagonista de il-4r para usarse en el tratamiento del asma.
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2015006234A (es) Uso de akkermansia para tratar trastornos metabolicos.
UY33396A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
MX2011007702A (es) Composiciones farmaceuticas que comprenden imidazoquinolin(aminas) y derivados de las mismas apropiados para administraccion local.
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
DOP2012000155A (es) Terapia combinada para el tratamiento del cancer y ensayos de diagnostico relacionados
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
MX366899B (es) Nuevos compuestos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
EA201590654A1 (ru) Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
EA201690187A1 (ru) Композиция в форме сухого порошка, содержащая кортикостероид и бета-адренергическое лекарственное средство, для введения ингаляцией
MX2015014344A (es) Terapia contra el cancer.
MX376183B (es) Composiciones para el tratamiento de rosacea.
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
CO6731081A2 (es) Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX381102B (es) Benralizumab para usarse en el tratamiento de asma incrementando el volumen espiratorio forzado.